APRINOIA Therapeutics Company

APRINOIA Therapeutics specializes in the diagnotics and therapeutics for Alzheimer's disease and tauopathies.
Technology: Anti-infective Drugs
Industry: PharmTech
Headquarters: Taipei, T'ai-pei, Taiwan
Founded Date: 2015
Employees Number: 11-50
Funding Status: Early Stage Venture
Investors Number: 5
Total Funding: 17530000
Estimated Revenue: $1M to $10M
Last Funding Date: 2019-05-23
Last Funding Type: Grant

Visit Website
contact@aprinoia.com
Register and Claim Ownership